Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.349NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.265NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.401NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.362NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FW.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BS.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.75.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CA.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.453NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.637.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.79NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BG.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-15533.3Singapore
XASNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.3.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BL.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.53 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.599NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.128NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.451NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.313NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.402NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.609NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.344NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.556NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.245NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.403NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.636NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.126NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.47NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDQ.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JD.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.31.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used